Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

05. Dezember 2016 08:00 ET | Quelle: Spectral Medical Inc.

Spectral Announces Appointment of Dr. Masayuki Kaneko to Its Board of Directors

TORONTO, ONTARIO--(Marketwired - Dec. 5, 2016) - Spectral Medical Inc. ("Spectral" or the "Company") (TSX:EDT) (OTCQX:EDTXF) a Phase III company developing the first treatment for...
11. November 2016 08:00 ET | Quelle: Spectral Medical Inc.

Spectral Announces Next Steps in Path Forward and Issues Third Quarter Results

TORONTO, ONTARIO--(Marketwired - Nov. 11, 2016) - Spectral Medical Inc., (TSX:EDT) (OTCQX:EDTXF), a Phase III company developing the first treatment for patients with septic shock guided...
03. Oktober 2016 08:02 ET | Quelle: Spectral Medical Inc.

Spectral Announces Clinical Trial Results

TORONTO, ONTARIO--(Marketwired - Oct. 3, 2016) - Spectral Medical Inc. ("Spectral" or the "Company") (TSX:EDT)(OTCQX:EDTXF) a Phase III company developing the first treatment for...
20. September 2016 14:05 ET | Quelle: Spectral Medical Inc.

Spectral Responds to Recent Trading Activity

TORONTO, ONTARIO--(Marketwired - Sept. 20, 2016) - Spectral Medical Inc. ("Spectral" or the "Company") (TSX:EDT) (OTCQX:EDTXF), at the request of IIROC on behalf of the Toronto Stock...
07. September 2016 08:00 ET | Quelle: Spectral Medical Inc.

Spectral Announces Participation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 11-13th, 2016

TORONTO, ONTARIO--(Marketwired - Sept. 7, 2016) - Spectral Medical Inc. ("Spectral" or the "Company") (TSX:EDT)(OTCQX:EDTXF) a Phase III Company advancing a precision treatment targeting...
19. August 2016 08:00 ET | Quelle: Spectral Medical Inc.

Spectral Unaware of Any Material Change

TORONTO, ONTARIO--(Marketwired - Aug. 19, 2016) - Spectral Medical Inc. (TSX:EDT)(OTCQX:EDTXF) ("Spectral" or the "Company"), a Phase III company developing the first treatment for...
18. August 2016 08:00 ET | Quelle: Spectral Medical Inc.

Spectral on Track With Regulatory Pathway for Novel Septic Shock Treatment

TORONTO, ONTARIO--(Marketwired - Aug. 18, 2016) - Spectral Medical Inc., (TSX:EDT) (OTCQX:EDTXF) (the "Company"), a Phase III company developing the first treatment for patients with...
12. August 2016 08:00 ET | Quelle: Spectral Medical Inc.

Spectral Announces Second Quarter Results

TORONTO, ONTARIO--(Marketwired - Aug. 12, 2016) - Spectral Medical Inc., (TSX:EDT) (OTCQX:EDTXF), a Phase III company developing the first treatment for patients with septic shock guided...
04. Juli 2016 08:00 ET | Quelle: Spectral Medical Inc.

Spectral Announces Normal Course Issuer Bid

TORONTO, ONTARIO--(Marketwired - July 4, 2016) - Spectral Medical Inc. ("Spectral" or the "Company") (TSX:EDT) (OTCQX:EDTXF) a Phase III Company advancing a precision treatment targeting...
27. Juni 2016 08:00 ET | Quelle: Spectral Medical Inc.

FDA Accepts Spectral's Expanded Access Protocol for Toraymyxin(TM)

TORONTO, ONTARIO--(Marketwired - June 27, 2016) - Spectral Medical Inc. ("Spectral" or the "Company"), (TSX:EDT)(OTCQX:EDTXF), a Phase III Company advancing a precision treatment...

Vorherige Seite

Nächste Seite